Abstract-New hydroxy azepanes with an additional hydroxymethyl side arm have been conceived and their syntheses achieved from a suitably functionalized cyclohexanoid building-block extracted from the norbornyl framework. The new iminocyclitols (homoisofagomine derivatives) exhibit weak but selective inhibitory activity in enzyme assays.
Replacement of ring oxygen with basic nitrogen in sugars gives rise to azasugars (also referred to as imino sugars) and these entities have not only been found in Nature but also aroused a great deal of synthetic interest in recent years because of their ability to inhibit glycosidases. 1 While deoxynojirimycin 1 constitutes a well known example of a potent naturally occuring glycosidase inhibitor, 1-deoxyfuconojirimycin 2 is a synthetic analogue 2a and the most powerful inhibitor of a-fucosidases known to date. This impressive biological activity profile of iminosugars and their potential for therapeutic applications has stimulated interest in the synthesis of newer analogues through manipulation of the number and stereochemical disposition of the hydroxyl groups, relocation of the hydroxymethyl arm as in the potent inhibitor isofagomine 3, 2b,c,e introduction of additional ring nitrogen atom as in the diazasugar 4 2d among others. More recently, iminocyclitols based on seven-membered rings having the same carbon content as the azasugars but endowed with the conformational advantage of a more flexible azepane ring that could lead to favorable binding to the active site of the enzyme have been introduced.
3 Indeed, iminocyclitols 5-7 have shown promising glycosidase inhibition profiles. We have visualized another variant of the seven-membered iminocyclitols with an additional binding site in the form of a hydroxymethyl arm, which can be regarded as a hybrid of the polyhydroxyazepanes and isofagomine 3. Syntheses of several of these new iminocyclitols 8 form the subject matter of this letter.
Recently, we have delineated a convenient access to a functionalized cyclohexenoid 10 from a norbornyl precursor 9 involving a fragmentation protocol. 4a It has been shown that 10 is a versatile building block, comparable to the cyclohexadiene-diols derived through microbial hydroxylation of arenes, 5 for the synthesis of diverse cyclitols and related structures. 4 Herein, we further demonstrate the utility of 10 in the synthesis of novel hydroxyazepanes related to 8 (Scheme 1). Elaboration of 10 to azepanes required oxidative cleavage of the cyclohexanoid ring to set-up either a double reductive amination or inter-and intramolecular N-alkylations to deliver system 8. Towards this end, 10 was transformed to the cis-1,2-diol 11 6 via LiAlH 4 reduction, protection of the resulting primary hydroxyl functionality and stereoselective catalytic OsO 4 dihydroxylation. Periodate mediated oxidative cleavage to the dialdehyde, sodium borohydride reduction and mesylation on 11 proceeded uneventfully to furnish the dimesylate 12 (Scheme 1). 6 Exposure of 12 to p-toluenesulfonamide under phase transfer conditions resulted in smooth inter-and the intramolecular N-alkylations to 13. The N-tosyl group in 13 could be reductively removed with sodium naphthalenide and the resulting free amine was characterized as the acetamide 14, which existed as a mixture of two rotamers. Deprotection maneuvers in 14 led to a homoisofagomine (carbon inserted between nitrogen and hydroxymethyl group of 3) derivative 15 (Scheme 1). 6 An isomeric homoisofagomine derivative with a carbon inserted between the hydroxymethyl group and the neighboring hydroxy group was also prepared from 10 through a tactically altered route. Cyclohexenoid 10 was first elaborated to 16 through LiAlH 4 reduction, stereoselective catalytic dihydroxylation and acetylation (Scheme 2). 6 Acetonide deprotection in 16 gave 17 and the 1,2-diol functionality was subjected to periodate cleavage to Scheme 1. Reagents and conditions: (a) i. LAH, THF, 0-5°C, 1 h, 90%, ii. BnBr, NaH, THF, rt, 6 h, 95%, iii. OsO 4 , NMMO, Me 2 CO-H 2 O (4:1), rt, overnight, 83%; (b) i. NaIO 4 -silica gel, DCM, 0°C, 2 h, ii. NaBH 4 , MeOH, 0°C, 1 h, iii. MsCl, Et 3 N, DCM, 0°C, 1.5 h, 55% (three steps); (c) pTsNH 2 , KOH, TBAI, C 6 H 6 -H 2 O (9:1), reflux, 24 h, 60%; (d) i. Na-naphthalenide, DME, −60°C, 1 h, ii. Ac 2 O, Py, rt, overnight, 67% (two steps); (e) i. H 2 , Pd/C, EtOH, 12 h, ii. 1N HCl, 90°C, 85% (two steps). deliver the intermediate dialdehyde 18, which was directly subjected to a double-reductive amination 7 to give the azepane 19 as the major product (Scheme 2). 6 While acetate hydrolysis in 19 gave the N-benzyl-protected trihydroxy azepane 20, reductive removal of the N-benzyl group and deprotection gave the trihydroxy azepane 21 (Scheme 2). 6 Another homoisofagomine related to 21 with a 'skipped hydroxyl' pattern was accessed from the endo-norbornyl derivative 22. Regioselective Baeyer-Villiger oxidation of 22 gave 23 as the major product (87:13 mixture of regioisomers). A sequence consisting of LiAlH 4 reduction, per-acetylation and acetonide deprotection in 23 led to cyclohexane-1,2-diol 24 (Scheme 3). 6 Periodate cleavage in 24 led to an intermediate dialdehyde 25, which was directly subjected to double-reductive amination with benzylamine to give the azepane triacetate 26 as the major product. Acetate hydrolysis in 26 gave the N-benzyl trihydroxy derivative 27. On the other hand, reductive removal of the N-benzyl group and acetate deprotection furnished the trihydroxyazepane 28 (Scheme 3). 6 The new homoisofagomine analogues 15, 20, 21, 27 and 28 were assayed for glycosidase inhibition against a set of six commonly used enzymes (a-and b-glucosidase, a-and b-galactosidase, and a-and b-mannosidase) following standard protocols. All the substrates examined exhibited weak but selective inhibition with 20 and 21 showing relatively better activity against b-glucosidase (K i =470 mM) and a-galactosidase (K i =600 mM), respectively. It is quite interesting that while the N-benzyl derivative 20 shows inhibition of b-glucosidase, the unprotected 21 inhibits a-galactosidase. This change in enzyme selectivity in the case of 20 and 21 mediated only by the protective group, without any alteration in the disposition or stereochemistry of the hydroxyl groups, is quite unusual and may have useful implications. We have observed similar selectivity in the case of 27 and 28, as well with the former exhibiting weak inhibition of b-glucosidase and the latter inhibiting a-glucosidase.
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In conclusion, we have amplified the synthetic utility of the cyclohexenoid building block 10 by devising stereoselective routes to new hydroxyazepanes with a homoisofagomine framework. While the azepanes reported here have only weak glycosidase inhibitory activity compared to those reported earlier, our results of enzymatic assays reveal the importance of N-substitution in modulating selectivity and inhibition efficacy.
